Automated blood grouping
Ended Awarded Last action
- Contract number
- N6809521F0012
- Awardee
-
Ortho-Clinical Diagnostics, Inc. UEI JG5JF2JQJ121
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $44,319
Award facts
- Contract value 42% obligated
-
- $44,319.35 Current, with exercised options
- $106,667.83 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$18,029 | |
| Original award | $62,348 |
About this award
Ortho-Clinical Diagnostics, Inc. was awarded a $106,667.83 delivery order for automated blood grouping equipment and services by the Defense Health Agency on September 28, 2021, with a completion date of September 27, 2023. This firm fixed-price contract, which utilized no set-aside designation, represents a task order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The work is to be performed at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics is a medical equipment manufacturer specializing in advanced diagnostic solutions for federal healthcare agencies, particularly in laboratory testing infrastructure including blood bank analyzers and related consumables.
This delivery order supports the Defense Health Agency's medical laboratory operations across the Military Health System. Ortho-Clinical Diagnostics maintains an extensive portfolio of federal healthcare contracts with agencies including the Department of Veterans Affairs, Indian Health Service, and National Institutes of Health, providing critical blood bank analyzer systems and associated reagents through similar GSA Schedule vehicles. The company, headquartered in Raritan, New Jersey and self-certified as a HUBZone joint venture through May 2026, leverages its established federal contracting relationships to supply specialized diagnostic equipment that enables blood testing capabilities at military treatment facilities and federal medical centers.
Quick answers
Who was awarded contract N6809521F0012?
N6809521F0012 was awarded to Ortho-Clinical Diagnostics, Inc. by Defense Health Agency (Department of Defense) on September 28, 2021.
How much is contract N6809521F0012 worth?
The government has obligated $44,319 on N6809521F0012. Its potential value, with all options, is $106,668.
Is contract N6809521F0012 an order under another contract?
Yes. N6809521F0012 is a delivery order under V797D60637, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract N6809521F0012 competed?
The extent of competition for N6809521F0012 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award